Literature DB >> 15789938

Patient reported outcomes in gastroesophageal reflux disease: an overview of available measures.

Nicholas J Talley1, Ingela Wiklund.   

Abstract

Gastroesophageal reflux disease (GERD) is a common, chronic disorder. The main symptom of GERD is heartburn, although a diverse range of symptoms can be associated with the disease including acid regurgitation and epigastric pain. GERD is also a risk factor for Barrett's oesophagus and esophageal adenocarcinoma. The impact of GERD symptoms on patients' lives can be profound and is unrelated to the presence or absence of esophagitis. The impact of GERD can be measured by assessing the patient perspective using Patient Reported Outcomes (PROs). There are two categories of questionnaires that can be used to measure the effect of GERD on health-related quality of life (HRQoL), namely generic and disease or treatment specific. The use of PRO instruments has become more accepted in the assessment of disease treatment. Well-designed instruments that assess physical, psychological and emotional factors can provide clinicians with the data that will promote effective management decisions for the treatment of GERD. The most frequently used instruments in GERD are reviewed here, in terms of their psychometric properties.

Entities:  

Mesh:

Year:  2005        PMID: 15789938     DOI: 10.1007/s11136-004-0613-5

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  82 in total

1.  Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.

Authors:  M A Eloubeidi; D Provenzale
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

Review 2.  Assessing meaningful change in quality of life over time: a users' guide for clinicians.

Authors:  Mirjam A G Sprangers; Carol M Moinpour; Timothy J Moynihan; Donald L Patrick; Dennis A Revicki
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616

Review 3.  Measuring quality of life in clinical trials: a taxonomy and review.

Authors:  G H Guyatt; S J Veldhuyzen Van Zanten; D H Feeny; D L Patrick
Journal:  CMAJ       Date:  1989-06-15       Impact factor: 8.262

Review 4.  Interpretation of quality of life changes.

Authors:  E Lydick; R S Epstein
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

5.  Diagnosis and management of gastroesophageal reflux disease in the primary care setting: can health-related quality of life play a role?

Authors:  I M Gralnek
Journal:  Am J Gastroenterol       Date:  2001-08       Impact factor: 10.864

Review 6.  Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature.

Authors:  A M Rentz; C Battista; E Trudeau; R Jones; P Robinson; S Sloan; S Mathur; L Frank; D A Revicki
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 7.  Methods to explain the clinical significance of health status measures.

Authors:  Gordon H Guyatt; David Osoba; Albert W Wu; Kathleen W Wyrwich; Geoffrey R Norman
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

8.  Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.

Authors:  E Dimenäs; G Carlsson; H Glise; B Israelsson; I Wiklund
Journal:  Scand J Gastroenterol Suppl       Date:  1996

Review 9.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

Review 10.  Endoscopic evaluation of gastro-esophageal reflux disease.

Authors:  D Armstrong
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun
View more
  9 in total

1.  Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.

Authors:  Malcolm Boyce; Sally Dowen; Gillian Turnbull; Frans van den Berg; Chun-Mei Zhao; Duan Chen; James Black
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

Review 2.  Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review.

Authors:  Sander Jo van Zanten; Catherine Henderson; Nesta Hughes
Journal:  Can J Gastroenterol       Date:  2012-04       Impact factor: 3.522

3.  Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants.

Authors:  Kathleen W Wyrwich; Reema Mody; Lois M Larsen; Misun Lee; Neesha Harnam; Dennis A Revicki
Journal:  Qual Life Res       Date:  2010-02-27       Impact factor: 4.147

Review 4.  PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.

Authors:  Garth Fuller; Roger Bolus; Cynthia Whitman; Jennifer Talley; M Haim Erder; Alain Joseph; Debra G Silberg; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2017-01-23       Impact factor: 3.199

Review 5.  Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders.

Authors:  Y Claire Dorsey; Erin J Song; David A Leiman
Journal:  Curr Gastroenterol Rep       Date:  2021-12-01

6.  Construct validity of the Psychological General Well Being Index (PGWBI) in a sample of patients undergoing treatment for stress-related exhaustion: a Rasch analysis.

Authors:  Åsa Lundgren-Nilsson; Ingibjörg H Jonsdottir; Gunnar Ahlborg; Alan Tennant
Journal:  Health Qual Life Outcomes       Date:  2013-01-07       Impact factor: 3.186

7.  Psychometric validation of the Dutch translation of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with gastroesophageal reflux disease.

Authors:  Leopold G J B Engels; Elly C Klinkenberg-Knol; Jonas Carlsson; Katarina Halling
Journal:  Health Qual Life Outcomes       Date:  2010-08-17       Impact factor: 3.186

8.  Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting.

Authors:  Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Javier Zapardiel
Journal:  Health Qual Life Outcomes       Date:  2009-07-02       Impact factor: 3.186

9.  Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study.

Authors:  Wei-Tao Liang; Zhong-Gao Wang; Feng Wang; Yue Yang; Zhi-Wei Hu; Jian-Jun Liu; Guang-Chang Zhu; Chao Zhang; Ji-Min Wu
Journal:  BMC Gastroenterol       Date:  2014-10-10       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.